Principal Project-Characterization of ANA+ and ANA-B cells in individuals with SLE and healthy subjects
- Institution
- FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH, NY
- Principal investigator
- Betty Diamond
- Funding
- $335K
- Duration
- 2019–2029
Moonbase score
Still being scored
Abstract
Little is known about the differences between B cells reactive with nuclear antigen (ANA+) and ANA- B cells in individuals with systemic lupus erythematosus (SLE) or whether the regulation of ANA+ and ANA- B cells differs between SLE patients and healthy individuals. We will study activation and transcriptional profile in ANA+ and ANA- naïve, unswitched memory and switched memory B cells in individuals with active SLE, individuals with SLE in remission and healthy individuals. We will determine the antigenic and BCR repertoire of ANA+ B cells in these three cohorts to understand B cell selection. These studies are designed to reveal if there are aspects of ANA+ B cells in SLE that makes them susceptible to a therapeutic intervention that will not affect those B cells engaged in a protective response.
LOADING MOONBASE SCORE
Questions for FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Feinstein Institute for Medical ResearchNot yet scored
Acquisition of high-parameter fluorescent-activated cell sorter analyzer
Betty Diamond · $689K · 2025–2026
- NIH · Feinstein Institute for Medical ResearchNot yet scored
Learning from Remission and Relapse in SLE
Betty Diamond · $133K · 2025–2029
- NIH · Feinstein Institute for Medical ResearchNot yet scored
Learning from Remission and Relapse in SLE
Betty Diamond · $91K · 2025–2029